Inventory of the Management of Acute Community-acquired Pneumonia in Strasbourg University Hospitals

Inventory of the Management of Acute Community-acquired Pneumonia in the Pneumology Department of the Strasbourg University Hospitals

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05661513

Acronym

PPAC

Enrollment

1000

Registered

2022-12-22

Start date

2022-09-09

Completion date

2025-03-09

Last updated

2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infection, Lung Parenchyma

Keywords

Community-acquired Pneumonia, Infection, Lung parenchyma, Rhinovirus, Respiratory syncitial virus, Influenza virus, Streptococcus pneumoniae

Brief summary

Acute community-acquired pneumonia (CAP) refers to an acute infection of the lung parenchyma, occurring within the first 48 hours of hospitalization. It is a frequent, serious pathology with a strong economic impact. Viruses (rhinovirus, respiratory syncitial virus, influenza virus for the most common) and Streptococcus pneumoniae are the most frequently encountered pathogens. However, more than half of the PACs have no microbiological documentation. The management of CAPs is based on national and international recommendations. Several studies have shown imperfect compliance by clinicians with recommendations with a prognostic impact. The various published studies insist on the variability of the incidence, the type of pathogen, the severity and the economic impact, depending on the series. They also insist on the need to know the local epidemiology, in particular microbiological, in order to adapt the recommendations.

Detailed description

The objective of the study is to determine the epidemiological, clinical, biological and imaging characteristics of people admitted for acute community-acquired pneumonia.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Inclusion criteria

* Adult subject (≥ 18 years old), * acute community-acquired pneumonia (\< 48 hours after admission), * admitted from the Emergency Department, consultation or home. * Subject not objecting to the reuse of their data for scientific research purposes

Exclusion criteria

* Expressed refusal to reuse data for scientific research purposes. * bronchitis, acute nosocomial pneumopathy, secondary infection due to bronchial dilation.

Design outcomes

Primary

Measure	Time frame	Description
Retrospectively determine the epidemiological, clinical, biological and imaging characteristics of people admitted for acute community-acquired pneumonia	Files analysed retrospectively from January 01, 2015 to December 31, 2019 will be examined	Retrospective analysis of health data from patients' medical records

Countries

France

Contacts

Primary ContactLoïc KASSEGNE, MD

loic.kassegne@chru-strasbourg.fr33 3 69 55 01 88

Outcome results